Mirataz 100 mg/tube in 5-gram tube (20 mg per 1 gram)

Description: Mirataz® Transdermal Ointment is used to manage weight loss in cats due to underlying diseases such as hyperthyroidism, chronic kidney disease, inflammatory bowel disease, neoplasia, pancreatitis, and liver failure.

Product: Mirataz® Transdermal Ointment

For: Cats

Generic Name: Mirtazapine

Brand Names: Mirataz®

Drug Class: Tetracyclic Antidepressant, 5–HT3 Antagonist

Manufacturer: Dechra

Product Description & Form: Mirataz® Transdermal Ointment 5 gm: white to off–white ointment. (NDC 17033–060–05)Mirataz® Transdermal Ointment 5 gm

Benefits:

Has been shown demonstrate increase body weight in cats that are experiencing unintended weight loss, it has been classified as a weight gain drug

First and only FDA approved transdermal medication for the management of weight loss in cats

Give you a practical way to manage your cat's weight loss without having to administer oral medication and does not rely on your cat to eat to be medicated

Can result in significant weight gain in cats in as little as 14 days

Due to proprietary Accusorb™ technology, Mirataz® achieves measurable plasma concentrations of mirtazapine in cats

Clinical studies showed Mirataz® was well tolerated both locally and systemically